GERMAINE THURMOND: Open Payments
NPI 1235614066 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 68 payments from 20 companies in 2025. Trend: 2023 $1,375 · 2024 $1,870 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $284 |
| Lilly USA, LLC | 10 | $251 |
| Novo Nordisk Inc | 12 | $162 |
| ABBVIE INC. | 12 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Exact Sciences Corporation | 3 | $57 |
| Edwards Lifesciences Corporation | 1 | $40 |
| PFIZER INC. | 2 | $36 |
Products named: AIRSUPRA, BREZTRI, ZEPBOUND, MOUNJARO, VRAYLAR, Ozempic, Kerendia, REXULTI.
Industry payments across LA — which companies pay providers there.
